HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazones.

Abstract
Triapine is an α-N-heterocyclic thiosemicarbazone with promising anticancer activity against hematologic malignancies but widely ineffective against solid tumor types in clinical trials. The anticancer activity of thiosemicarbazones can be dramatically increased by terminal dimethylation. KP1089 is a gallium compound containing two terminal dimethylated thiosemicarbazone ligands. To gain insights on the vulnerability of this highly active terminal dimethylated thiosemicarbazone to drug resistance mechanisms, a new cell model with acquired resistance against the lead compound KP1089 was established. Subsequent genomic analyses (arrayCGH and FISH) revealed amplification of the ABCC1 gene on double minute chromosomal DNA in KP1089-resistant cells as well as overexpression of ABCC1 and ABCG2 on the protein level. KP1089 was further confirmed as a substrate of ABCC1 and ABCG2 but not of ABCB1 using a panel of ABC transporter-overexpressing cell models as well as ABC transporter inhibitors. Moreover, glutathione depletion strongly enhanced KP1089 activity, although no glutathione conjugate formation by glutathione-S-transferase was observed. Thus, a co-transport of KP1089 together with glutathione is suggested. Finally, a panel of thiosemicarbazone derivatives was tested on the new KP1089-resistant cell line. Notably, KP1089-resistant cells were not cross-resistant against thiosemicarbazones lacking terminal dimethylation (e.g. Triapine) which are less active than KP1089. This suggests that terminal dimethylation of thiosemicarbazones - linked with distinctly enhanced anticancer activity - leads to altered resistance profiles compared to classical thiosemicarbazones making this compound class of interest for further (pre)clinical evaluation.
AuthorsPetra Heffeter, Christine Pirker, Christian R Kowol, Gerrit Herrman, Rita Dornetshuber, Walter Miklos, Ute Jungwirth, Gunda Koellensperger, Bernhard K Keppler, Walter Berger
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 83 Issue 12 Pg. 1623-33 (Jun 15 2012) ISSN: 1873-2968 [Electronic] England
PMID22426010 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • ABCG2 protein, human
  • Antineoplastic Agents
  • Heterocyclic Compounds
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins
  • Thiosemicarbazones
  • multidrug resistance-associated protein 1
  • Glutathione
Topics
  • ATP-Binding Cassette Transporters (genetics)
  • Antineoplastic Agents (chemistry, pharmacology)
  • Blotting, Western
  • Cell Line, Tumor
  • Comparative Genomic Hybridization
  • Drug Resistance, Neoplasm
  • Glutathione (metabolism)
  • Heterocyclic Compounds (chemistry, pharmacology)
  • Humans
  • In Situ Hybridization, Fluorescence
  • Methylation
  • Multidrug Resistance-Associated Proteins (genetics)
  • Neoplasm Proteins (genetics)
  • Thiosemicarbazones (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: